Gubra A/S Stock: price and insider trades · Denmark
No insider purchase over the last 90 days. The latest, by Niels Vrang, was filed 11 May 2026.
Gubra A/S: what insiders have been doing
Gubra A/S, founded in 2008, is a Healthcare & Pharma company based in Denmark. Its directors and officers file their transactions with Finanstilsynet DK. The last twelve months, up to 8 November 2026, brought 11 filings signed by 4 insiders.
The record shows 5 purchases on the open market worth €3.8M, made by 3 insiders, against 1 sale worth €113k by 1 insider. Purchases outweigh sales by €3.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €2.0M, bought by Jacob Jelsing and made public on 10 November 2025 (0.23% of market cap).
The latest purchase dates back some time: it was published 180 days ago, on 11 May 2026. The median gap between a trade and its publication by Finanstilsynet DK is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
Across the 72 companies tracked on its exchange, the median is 5 filings; at 11 filings, this issuer sits above that mark. Looking back to 2023, when coverage begins, insiders filed 11 purchases and 4 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.
Key facts
Headquarters: Denmark · Founded: 2008
Source: Wikidata (CC0).
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 138 shares@ DKK 358.520.0008% mcap2.3% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1448725
- 1,312 shares@ DKK 358.520.0073% mcap22.2% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1448724
- 2,500 shares@ DKK 339.380.013% mcap40.0% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1447498
- 20,189 shares@ DKK 37.39170.012% mcap35.6% of flowShareOutside a trading venueISIN DK0062266474DK:1447497
- 7 shares@ €1.0854ShareOutside a trading venueISIN DK0062266474DK:1446387
- 7 shares@ €4.1625ShareOutside a trading venueISIN DK0062266474DK:1446385
- 1,425 shares@ DKK 321.2080.0071% mcap0.1% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1441280Canonical exit: 6 Aug 2026 (T+90)
- 20,000 shares@ DKK 381.37252.4% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1423694Canonical exit: 31 May 2026 (T+90)
- 10,000 shares@ DKK 487.99770.075% mcap1.5% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1406879Canonical exit: 17 Mar 2026 (T+90)
- 385 shares@ DKK 387.820.23% mcap4.6% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1399826Canonical exit: 5 Feb 2026 (T+90)
- 379 shares@ DKK 392.620.0023% mcap0.0% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1399794Canonical exit: 5 Feb 2026 (T+90)
- 4,300 shares@ DKK 373.610.025% mcap0.5% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1399538Canonical exit: 5 Feb 2026 (T+90)
- 6,385 shares0ShareOutside a trading venueISIN DK0062266474DK:1377391
- 11,186 shares0ShareOutside a trading venueISIN DK0062266474DK:1377390
- 532 shares@ DKK 530.000.025% mcap0.5% of flowShareNASDAQ Copenhagen A/SISIN DK0062266474DK:1305914
- 53,000 shares@ DKK 576.000.47% mcap9.5% of flowShareOutside a trading venueISIN DK0062266474DK:1304823
- 306 shares@ DKK 478.000.0023% mcap0.0% of flowShareNASDAQ Copenhagen A/SISIN DK0062266474DK:1304004Canonical exit: 26 Sept 2024 (T+90)
- 7,291 shares0ShareOutside a trading venueISIN DK0062266474DK:1300084
- 12,245 shares0ShareOutside a trading venueISIN DK0062266474DK:1300083
- 6,818 shares0ShareOutside a trading venueISIN DK0062266474DK:1285571Canonical exit: 2 Jul 2024 (T+90)
- 10,909 shares0ShareOutside a trading venueISIN DK0062266474DK:1285570Canonical exit: 2 Jul 2024 (T+90)
- 280 shares@ DKK 284.000.0012% mcap0.0% of flowShareNASDAQ CopenhagenISIN DK0062266474DK:1284343Canonical exit: 25 Jun 2024 (T+90)
- 500,000 shares@ DKK 300.002.32% mcap46.5% of flowShareOutside a trading venueISIN DK0062266474DK:1283502
- 889 shares@ DKK 215.330.0030% mcap0.1% of flowShareNASDAQ Copenhagen AISIN DK0062266474DK:1279111Canonical exit: 2 Jun 2024 (T+90)
- 20,189 shares0ShareOutside a trading venueISIN DK0062266474DK:1231786
25 of 34 declarations
About Gubra A/S
Gubra A/S is a Danish company focused on research and development of treatments for metabolic diseases. It emphasizes innovation in the healthcare and pharmaceutical sectors.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
